Published • loading... • Updated
Cencora, Kite Expand CAR-T Distribution Network as Access Grows
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cencora, Kite Expand CAR-T Distribution Network as Access Grows
CONSHOHOCKEN, PA — Cencora has entered an agreement with Kite, a unit of Gilead Sciences, to distribute two FDA-approved CAR T-cell cancer therapies across a growing network of treatment centers, a move aimed at expanding access to one of oncology’s most complex and resource-intensive treatment categories. The agreement covers Yescarta and Tecartus, Kite’s approved CAR T-cell therapies, and comes as the company broadens the number of authorized …
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
